Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Future Oncol. 2021 Dec;17(35):4823-4825. doi: 10.2217/fon-2021-1107. Epub 2021 Oct 21.
No abstract available

Keywords: breast cancer; hormonal therapy; hypertriglyceridemia; side effects; tamoxifen.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy*
  • Drug Monitoring
  • Female
  • Humans
  • Hypertriglyceridemia / chemically induced
  • Hypertriglyceridemia / diagnosis
  • Lipids / blood*
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Lipids
  • Tamoxifen